Universal WBC reduction: the case for and against (Q34247853)

31 July 2017

1 reference

title

Universal WBC reduction: the case for and against (English)

1 reference

31 July 2017

Vamvakas EC

1

1 reference

31 July 2017

Blajchman MA

series ordinal

2

1 reference

31 July 2017

publication date

1 May 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

41

1 reference

31 July 2017

issue

5

1 reference

31 July 2017

page(s)

691-712

1 reference

Leukocyte reduction of blood components: public policy and new technology

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Cost-effectiveness of white cell-reduction filters in treatment of adult acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

New variant Creutzfeldt-Jakob disease (nvCJD): the risk of transmission by blood transfusion and the potential benefit of leukocyte-reduction of blood components

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Allogeneic blood transfusions, immunomodulation, and postoperative bacterial infection: do we have the answers yet?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Beneficial effects of leukocyte depletion of transfused blood on postoperative complications in patients undergoing cardiac surgery: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Randomized trial comparing packed red cell blood transfusion with and without leukocyte depletion for gastrointestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Relationship between blood transfusion and tumour behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Blood transfusion and postoperative septic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Transfusion-associated cancer recurrence and postoperative infection: meta-analysis of randomized, controlled clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Mechanisms of transfusion-induced immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Structure of HLA molecules and immunosuppressive effects of HLA derived peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Induction of tolerance toward rat cardiac allografts by treatment with allochimeric class I MHC antigen and FTY720.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Induction of tolerance by intrathymic inoculation of alloantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The tumor growth-promoting effect of allogeneic blood transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Unusual kinetics of white cell clearance in transfused mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Meta-analysis in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Platelet production in the Old World--and the New.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Multicenter randomized controlled trials in transfusion medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

How double blind is double blind? And does it matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Detrimental effects of perioperative blood transfusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The immunobiology of eosinophils

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Transfusion and postoperative pneumonia in coronary artery bypass graft surgery: effect of the length of storage of transfused red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The role of the plasma from platelet concentrates in transfusion reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Increased tumor necrosis factor alpha (TNF alpha), interleukin 1, and interleukin 6 (IL-6) levels in the plasma of stored platelet concentrates: relationship between TNF alpha and IL-6 levels and febrile transfusion reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus white cell-reduced blood to patients undergoing arthroplasty. I. Proliferative T-cell responses and the balance of helper and suppressor T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Immunologic changes after transfusion of autologous or allogeneic buffy coat-poor versus WBC-reduced blood transfusions in patients undergoing arthroplasty. II. Activation of T cells, macrophages, and cell-mediated lympholysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Blood transfusion, blood storage and immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Prestorage versus poststorage white cell reduction for the prevention of the deleterious immunomodulatory effects of allogeneic blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Association of mortality with age of blood transfused in septic ICU patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The membrane and the lesions of storage in preserved red cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The red cell storage lesion and its implication for transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Human immunodeficiency virus type 1 activation after blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Transfusion of blood components to persons infected with human immunodeficiency virus type 1: relationship to opportunistic infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Evidence-based medicine. A new approach to teaching the practice of medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

A randomized controlled trial comparing plasma removal with white cell reduction to prevent reactions to platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Transfusion medicine. First of two parts--blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Why data bases should not replace randomized clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Randomized, controlled trials, observational studies, and the hierarchy of research designs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

A comparison of observational studies and randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Cost-effectiveness of expanded human immunodeficiency virus-testing protocols for donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The cost effectiveness of preoperative autologous blood donations

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Identification of the blood component responsible for increased susceptibility to gut-derived infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Febrile transfusion reaction: what blood component should be given next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

The cytomegalovirus-"safe" blood product: is leukoreduction equivalent to antibody screening?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Prevention of transfusion-transmitted cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Prevention of posttransfusion CMV in the era of universal WBC reduction: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Allo-immunization elicits CD8+ T cell-derived chemokines, HIV suppressor factors and resistance to HIV infection in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Blood transfusion and non-Hodgkin lymphoma: lack of association

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Leukocyte-depleted reperfusion of transplanted human hearts prevents ultrastructural evidence of reperfusion injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Impact of blood transfusions on inflammatory mediator release in patients undergoing cardiac surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

Cardiovascular and metabolic response to red blood cell transfusion in critically ill volume-resuscitated nonsurgical patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1537-2995.2001.41050691.X

10.1046/J.1537-2995.2001.41050691.X

21 January 2018

Identifiers

DOI

1 reference

31 July 2017

1 reference